In line with these results, we suppose that short allelic variant of (GT)n HMOX1 promoter predisposes ALL patients to higher number of CIN incidents, and thus may help identify patients at greater risk for such complications. Here, HMOX1 is linked to acute lymphoblastic leukemia.